Product Information

MILI 0.25-0.035 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.1067 per EA under NDC 65862077628. Its NADAC has been published 214 times since Oct 19, 2022.

FDA first approved this application on Jul 7, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

MILI 0.25-0.035 MG TABLET

norgestimate and ethinyl estradiol
$0.1067per EA

NDC

65862077628

Classification

Generic

Dosage Form

KIT

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA205449

FDA Approved

7/7/2016

TE Code

AB

On Market Since

7/7/2016

Price Statistics

The NADAC for MILI 0.25-0.035 MG TABLET has been published 214 times since Oct 19, 2022, and over the history we have for it it has declined 28.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1067 per EA
All-time high$0.1552 (Sep 13, 2023)
All-time low$0.1011 (Nov 20, 2024)
52-week high$0.1260
52-week low$0.1067
Median price$0.1278
Average price$0.1282
Largest weekly change-21.9% (Nov 20, 2024)
Weeks tracked214
Tracking sinceOct 19, 2022

Price History

1W

-3.9%

1M

-3.9%

3M

-10.3%

6M

-14.9%

1Y

-13.7%

3Y

-13.0%

5Y

N/A

All

-28.2%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of MILI 0.25-0.035 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for MILI 0.25-0.035 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.1067 per EA (NDC 65862077628), effective Nov 18, 2026.

How has the price of MILI 0.25-0.035 MG TABLET changed over time?

Over the history we have for it, the NADAC for MILI 0.25-0.035 MG TABLET has declined 28.2%. It has been tracked across 214 weekly CMS publications since Oct 19, 2022.

What are the highest and lowest recorded NADAC prices for MILI 0.25-0.035 MG TABLET?

Since Oct 19, 2022, the NADAC for MILI 0.25-0.035 MG TABLET has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.1552 (Sep 13, 2023), with a median of $0.1278 per EA.

Are there cheaper alternatives to MILI 0.25-0.035 MG TABLET?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as MILI 0.25-0.035 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures MILI 0.25-0.035 MG TABLET?

MILI 0.25-0.035 MG TABLET (NDC 65862077628) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.